(
(
Healthcare
Healthcare
)
)
Novel transcatheter mitral valve replacement
Novel transcatheter mitral valve replacement
Novel transcatheter mitral valve replacement
STATUS:
Current
HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients.
HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients.
(Entrepreneurs)
(Entrepreneurs)
Stefan Pilz, CEO
Steve Backer, COO
Prof. Stephen Brecker, CMO
(VI Partners)
(VI Partners)
(Fund)
(Fund)
Vi-21
Portfolio News
APR 07, 2025
HighLife granted US FDA Breakthrough Device Designation for its TMVR solution
Read More
Read more
APR 07, 2025
HighLife granted US FDA Breakthrough Device Designation for its TMVR solution
Read More
Read more
JAN 03, 2022
HighLife’s TSMVR Technology successfully used for the first time in China
Read More
Read more
JAN 03, 2022
HighLife’s TSMVR Technology successfully used for the first time in China
Read More
Read more
DEC 11, 2020
VI Partners invests in Highlife Medical
Read More
Read more
DEC 11, 2020
VI Partners invests in Highlife Medical
Read More
Read more